126 related articles for article (PubMed ID: 36798079)
1. Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma
Liu M; Hu T; Gou W; Chang H; Li Y; Li Y; Zuo D; Hou W; Jiao S
Front Pharmacol; 2023; 14():1140018. PubMed ID: 36798079
[TBL] [Abstract][Full Text] [Related]
2. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma
Liu M; Hu T; Gou W; Chang H; Li Y; Li Y; Zuo D; Hou W; Jiao S
Front Pharmacol; 2022; 13():993022. PubMed ID: 36467051
[No Abstract] [Full Text] [Related]
3. Corrigendum: Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment.
Sun W; Li M; Xie L; Mai Z; Zhang Y; Luo L; Yan Z; Li Z; Dong H; Huang F; Shen Z; Jiang Z
Front Pharmacol; 2021; 12():739503. PubMed ID: 34366874
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Wuzi Yanzong pill-Based on network pharmacology and
Chen WQ; Ding CF; Yu J; Wang CY; Wan LY; Hu HM; Ma JX
Front Pharmacol; 2022; 13():1129448. PubMed ID: 36712666
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke.
Liu C; Du L; Zhang S; Wang H; Kong L; Du G
Front Pharmacol; 2023; 14():1155574. PubMed ID: 36865916
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities.
Zhang J; Yang Z; Jia X; Li X; Wang X; Rong H; Liang Y; Zeng W; Jia W; Ma X
Front Pharmacol; 2022; 13():1080645. PubMed ID: 36479197
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: An integrative serum pharmacology-based approach to study the anti-tumor activity of B. Paniculatum aqueous bulb extract on the human hepatocellular carcinoma cell line BEL-7404.
Feng X; Ma G; Shi H; Wang Y; Chao X
Front Pharmacol; 2022; 13():1054143. PubMed ID: 36425573
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Exploring the pharmacological action mechanism of
Frontiers Production Office
Front Pharmacol; 2022; 13():1089017. PubMed ID: 36467070
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support
Tang D; Wang RY; Sun KW; Wu Y; Ding L; Mo Y
Front Pharmacol; 2022; 13():1105804. PubMed ID: 36532739
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Integrated chemical interpretation and network pharmacology analysis to reveal the anti-liver fibrosis effect of
Du Z; Huang D; Shi P; Dong Z; Wang X; Li M; Chen W; Zhang F; Sun L
Front Pharmacol; 2022; 13():986072. PubMed ID: 36016552
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum:
Li MT; Liu LL; Zhou Q; Huang LX; Shi YX; Hou JB; Lu HT; Yu B; Chen W; Guo ZY
Front Pharmacol; 2023; 14():1207268. PubMed ID: 37361230
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury.
Fu X; Ma B; Zhou M; Cheng Y; Liu L; Kan S; Liu C; Zhao X; Feng S; Zhu H; Hu W; Jiang Z; Zhu R
Front Mol Neurosci; 2023; 16():1257836. PubMed ID: 37564784
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.
Liu Y; Tan Y; Huang J; Wu C; Fan X; Stalin A; Lu S; Wang H; Zhang J; Zhang F; Wu Z; Li B; Huang Z; Chen M; Cheng G; Mou Y; Wu J
Front Pharmacol; 2023; 14():1243304. PubMed ID: 37564177
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of icaritin on proliferation, migration, and invasion of human nasopharyngeal carcinoma cell CNE2 by regulating STAT3 activation.
Li X; Li C; Zhou P; Chen S
Pharmazie; 2019 Nov; 74(11):685-687. PubMed ID: 31739838
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease with a deep learning algorithm.
Yan YC; Xu ZH; Wang J; Yu WB
Front Pharmacol; 2022; 13():1115043. PubMed ID: 36712677
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Quercetin Attenuates Atherosclerosis
Jiang YH; Jiang LY; Wang YC; Ma DF; Li X
Front Pharmacol; 2020; 11():772. PubMed ID: 32547390
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritis.
Wu J; Wang K; Liu Q; Li Y; Huang Y; Liu Y; Cai J; Yin C; Li X; Yu H; Meng W; Wang H; Lu A; Li Y; Guan D
Front Pharmacol; 2023; 14():1302388. PubMed ID: 37876729
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
Zhang Q; Chen W; Lv X; Weng Q; Chen M; Cui R; Liang G; Ji J
Front Pharmacol; 2022; 13():806724. PubMed ID: 35899109
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer's disease.
Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
Front Pharmacol; 2023; 14():1239060. PubMed ID: 37869758
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson's disease by suppressing the JNK/AP-1 pathway.
Wang L; Yang YF; Chen L; He ZQ; Bi DY; Zhang L; Xu YW; He JC
Front Pharmacol; 2023; 14():1320322. PubMed ID: 38186655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
